Childhood systemic lupus erythematosus: A review of 30 cases

A. Buoncompagni, G. C. Barbano, V. Pistoia, L. Fasce, C. Micalizzi, R. Gusmano, G. Cordone, F. Cottafava, P. G. Mori, E. Franchini, M. Ferrarini, C. Borrone

Research output: Contribution to journalArticle

Abstract

We review 30 cases of pediatric systemic lupus erythematosus followed over an 8-year period at our institution. The female to male ratio was 3.3:1; the age at diagnosis ranged between 3.5 and 16 years. On first admission, renal involvement was detected in the majority of the patients, as assessed by laboratory findings and/or clinical manifestations. Other frequently observed symptoms were fever, skin rashes, arthralgias and/or arthritis and serositis. All of the patients were treated with corticosteroids and most of them also received immunosuppressive drugs in order to control disease activity. Two patients were lost to the follow-up, five died and only one of the 23 evaluable patients is off therapy after a median follow-up of 5 years. This study confirms that pediatric systemic lupus erythematosus is a very aggressive disease.

Original languageEnglish
Pages (from-to)425-430
Number of pages6
JournalClinical and Experimental Rheumatology
Volume9
Issue number4
Publication statusPublished - 1991

Fingerprint

Systemic Lupus Erythematosus
Serositis
Pediatrics
Lost to Follow-Up
Arthralgia
Immunosuppressive Agents
Exanthema
Arthritis
Adrenal Cortex Hormones
Fever
Kidney
Pharmaceutical Preparations
Therapeutics

ASJC Scopus subject areas

  • Immunology
  • Rheumatology

Cite this

Buoncompagni, A., Barbano, G. C., Pistoia, V., Fasce, L., Micalizzi, C., Gusmano, R., ... Borrone, C. (1991). Childhood systemic lupus erythematosus: A review of 30 cases. Clinical and Experimental Rheumatology, 9(4), 425-430.

Childhood systemic lupus erythematosus : A review of 30 cases. / Buoncompagni, A.; Barbano, G. C.; Pistoia, V.; Fasce, L.; Micalizzi, C.; Gusmano, R.; Cordone, G.; Cottafava, F.; Mori, P. G.; Franchini, E.; Ferrarini, M.; Borrone, C.

In: Clinical and Experimental Rheumatology, Vol. 9, No. 4, 1991, p. 425-430.

Research output: Contribution to journalArticle

Buoncompagni, A, Barbano, GC, Pistoia, V, Fasce, L, Micalizzi, C, Gusmano, R, Cordone, G, Cottafava, F, Mori, PG, Franchini, E, Ferrarini, M & Borrone, C 1991, 'Childhood systemic lupus erythematosus: A review of 30 cases', Clinical and Experimental Rheumatology, vol. 9, no. 4, pp. 425-430.
Buoncompagni A, Barbano GC, Pistoia V, Fasce L, Micalizzi C, Gusmano R et al. Childhood systemic lupus erythematosus: A review of 30 cases. Clinical and Experimental Rheumatology. 1991;9(4):425-430.
Buoncompagni, A. ; Barbano, G. C. ; Pistoia, V. ; Fasce, L. ; Micalizzi, C. ; Gusmano, R. ; Cordone, G. ; Cottafava, F. ; Mori, P. G. ; Franchini, E. ; Ferrarini, M. ; Borrone, C. / Childhood systemic lupus erythematosus : A review of 30 cases. In: Clinical and Experimental Rheumatology. 1991 ; Vol. 9, No. 4. pp. 425-430.
@article{a60bd88f86344c27af2b384e62c87ac6,
title = "Childhood systemic lupus erythematosus: A review of 30 cases",
abstract = "We review 30 cases of pediatric systemic lupus erythematosus followed over an 8-year period at our institution. The female to male ratio was 3.3:1; the age at diagnosis ranged between 3.5 and 16 years. On first admission, renal involvement was detected in the majority of the patients, as assessed by laboratory findings and/or clinical manifestations. Other frequently observed symptoms were fever, skin rashes, arthralgias and/or arthritis and serositis. All of the patients were treated with corticosteroids and most of them also received immunosuppressive drugs in order to control disease activity. Two patients were lost to the follow-up, five died and only one of the 23 evaluable patients is off therapy after a median follow-up of 5 years. This study confirms that pediatric systemic lupus erythematosus is a very aggressive disease.",
author = "A. Buoncompagni and Barbano, {G. C.} and V. Pistoia and L. Fasce and C. Micalizzi and R. Gusmano and G. Cordone and F. Cottafava and Mori, {P. G.} and E. Franchini and M. Ferrarini and C. Borrone",
year = "1991",
language = "English",
volume = "9",
pages = "425--430",
journal = "Clinical and Experimental Rheumatology",
issn = "0392-856X",
publisher = "Clinical and Experimental Rheumatology S.A.S.",
number = "4",

}

TY - JOUR

T1 - Childhood systemic lupus erythematosus

T2 - A review of 30 cases

AU - Buoncompagni, A.

AU - Barbano, G. C.

AU - Pistoia, V.

AU - Fasce, L.

AU - Micalizzi, C.

AU - Gusmano, R.

AU - Cordone, G.

AU - Cottafava, F.

AU - Mori, P. G.

AU - Franchini, E.

AU - Ferrarini, M.

AU - Borrone, C.

PY - 1991

Y1 - 1991

N2 - We review 30 cases of pediatric systemic lupus erythematosus followed over an 8-year period at our institution. The female to male ratio was 3.3:1; the age at diagnosis ranged between 3.5 and 16 years. On first admission, renal involvement was detected in the majority of the patients, as assessed by laboratory findings and/or clinical manifestations. Other frequently observed symptoms were fever, skin rashes, arthralgias and/or arthritis and serositis. All of the patients were treated with corticosteroids and most of them also received immunosuppressive drugs in order to control disease activity. Two patients were lost to the follow-up, five died and only one of the 23 evaluable patients is off therapy after a median follow-up of 5 years. This study confirms that pediatric systemic lupus erythematosus is a very aggressive disease.

AB - We review 30 cases of pediatric systemic lupus erythematosus followed over an 8-year period at our institution. The female to male ratio was 3.3:1; the age at diagnosis ranged between 3.5 and 16 years. On first admission, renal involvement was detected in the majority of the patients, as assessed by laboratory findings and/or clinical manifestations. Other frequently observed symptoms were fever, skin rashes, arthralgias and/or arthritis and serositis. All of the patients were treated with corticosteroids and most of them also received immunosuppressive drugs in order to control disease activity. Two patients were lost to the follow-up, five died and only one of the 23 evaluable patients is off therapy after a median follow-up of 5 years. This study confirms that pediatric systemic lupus erythematosus is a very aggressive disease.

UR - http://www.scopus.com/inward/record.url?scp=0025875767&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025875767&partnerID=8YFLogxK

M3 - Article

C2 - 1934695

AN - SCOPUS:0025875767

VL - 9

SP - 425

EP - 430

JO - Clinical and Experimental Rheumatology

JF - Clinical and Experimental Rheumatology

SN - 0392-856X

IS - 4

ER -